Skip to main content
Industry News
EMA begins rolling review for Russian COVID-19 vaccine
3/5/2021

A rolling review has been launched by the European Medicines Agency's Committee for Medicinal Products for Human Use for Russia’s Sputnik V COVID-19 vaccine. Developed by the Gamaleya National Centre of Epidemiology and Microbiology in Russia, the application in Europe for Sputnik V was filed by R-Pharm Germany.

Full Story: